Hospital
Braxton County Memorial Hospital
Braxton County Memorial Hospital was paid $2.21M by Medicaid between Jan 2018 and Dec 2024, across 112 billing codes. Its largest line is 99285, emergency room visit (most serious) — 13% of everything it billed.
33Billing provider infoBRAXTON COUNTY MEMORIAL HOSPITAL
GASSAWAY, WV 26624
GASSAWAY, WV 26624
33aNPI1285025825assigned 02/17/2015
33bProvider typeCritical Access Hospital
28Total paid$2.21M
24GClaims107,149
24DCodes billed112
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in West Virginia
Rank by total paid#18 of 24
Median peer was paid$3.57M
This provider vs. median0.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 16,347 | $552K | |
| 2019 | 14,728 | $319K | |
| 2020 | 12,894 | $267K | |
| 2021 | 16,190 | $319K | |
| 2022 | 17,014 | $275K | |
| 2023 | 15,944 | $232K | |
| 2024incomplete | 14,032 | $247K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 13% | 3,873 | 2,847 | $281K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 10% | 5,538 | 3,839 | $226K |
| 70450 | Computed tomography, head or brain; without contrast material | 6.7% | 1,017 | 927 | $148K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 6.3% | 3,689 | 2,863 | $138K |
| 80053 | Comprehensive metabolic panel | 4.7% | 6,714 | 5,443 | $104K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 4.3% | 2,643 | 2,008 | $95K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3.8% | 4,176 | 3,375 | $85K |
| 84484 | 3.7% | 3,884 | 2,790 | $82K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.4% | 7,443 | 5,694 | $76K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 3.1% | 256 | 236 | $68K |
| 96375 | Therapeutic injection; each additional sequential IV push | 2.9% | 3,078 | 2,348 | $63K |
| 71045 | Radiologic examination, chest; single view | 2.8% | 3,094 | 2,522 | $61K |
100 more codes
| 80048 | Basic metabolic panel (calcium, ionized) | 2.5% | 3,572 | $56K |
| 71046 | Radiologic examination, chest; 2 views | 1.9% | 1,304 | $41K |
| 83690 | 1.8% | 2,297 | $41K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.7% | 2,147 | $38K |
| 83880 | 1.5% | 2,070 | $34K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.3% | 75 | $29K |
| 82550 | 1.3% | 2,185 | $29K | |
| 82553 | 1.2% | 1,058 | $26K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1.1% | 1,121 | $25K |
| 83735 | 1.1% | 2,216 | $24K | |
| 36415 | Collection of venous blood by venipuncture | 1.0% | 9,489 | $23K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1.0% | 515 | $23K |
| 83605 | 1.0% | 2,563 | $22K | |
| G0378 | Hospital observation service, per hour | <1% | 376 | $22K |
| 87040 | <1% | 1,002 | $22K | |
| 82248 | <1% | 1,863 | $21K | |
| 80061 | Lipid panel | <1% | 995 | $21K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,542 | $20K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 570 | $19K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 688 | $19K |
| 85027 | <1% | 2,824 | $18K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,135 | $17K |
| 82803 | <1% | 392 | $15K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 163 | $12K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 572 | $12K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 567 | $11K |
| 81001 | <1% | 2,358 | $11K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 123 | $9K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 92 | $8K |
| 81003 | <1% | 876 | $8K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 654 | $7K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 953 | $7K |
| 85610 | <1% | 850 | $6K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 310 | $6K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,368 | $6K |
| 0099U | <1% | 12 | $5K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 52 | $5K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 261 | $5K |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 110 | $4K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 2,445 | $4K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 46 | $4K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 248 | $4K |
| 85007 | <1% | 1,442 | $4K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 48 | $3K |
| 96376 | <1% | 277 | $3K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 58 | $3K |
| 71250 | <1% | 14 | $3K | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 135 | $2K |
| 80050 | General health panel | <1% | 28 | $2K |
| 85730 | <1% | 216 | $2K | |
| 87186 | <1% | 259 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,622 | $2K |
| 73630 | <1% | 34 | $1K | |
| 96367 | <1% | 97 | $1K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 334 | $1K |
| 82962 | <1% | 166 | $1K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 297 | $1K |
| 74022 | <1% | 20 | $950.84 | |
| P9016 | Red blood cells, leukocytes reduced, each unit | <1% | 12 | $934.20 |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | <1% | 29 | $828.12 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 58 | $757.29 |
| 87077 | <1% | 95 | $688.55 | |
| 82150 | <1% | 40 | $586.98 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 28 | $586.66 |
| 85379 | <1% | 59 | $471.63 | |
| 87581 | <1% | 53 | $469.99 | |
| 73030 | <1% | 16 | $465.21 | |
| 87486 | <1% | 52 | $462.64 | |
| 82607 | <1% | 27 | $442.63 | |
| 83540 | <1% | 53 | $436.44 | |
| 82805 | <1% | 29 | $398.09 | |
| 82948 | <1% | 47 | $325.61 | |
| 86922 | <1% | 13 | $323.11 | |
| 36600 | <1% | 31 | $251.07 | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 83 | $241.92 |
| 36430 | <1% | 13 | $241.53 | |
| 94760 | <1% | 29 | $225.24 | |
| 82570 | <1% | 44 | $211.27 | |
| 87205 | <1% | 39 | $174.38 | |
| 87088 | <1% | 12 | $173.77 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 16 | $168.07 |
| J2704 | Injection, propofol, 10 mg | <1% | 32 | $157.29 |
| 94761 | <1% | 26 | $155.92 | |
| 82043 | <1% | 14 | $147.56 | |
| 82728 | <1% | 14 | $126.86 | |
| 87070 | <1% | 14 | $117.94 | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 24 | $111.16 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 31 | $102.00 |
| 86140 | <1% | 15 | $89.75 | |
| 94664 | <1% | 18 | $81.76 | |
| 86850 | <1% | 14 | $75.15 | |
| 86901 | <1% | 13 | $71.53 | |
| 86900 | <1% | 13 | $71.52 | |
| 85652 | <1% | 12 | $69.43 | |
| J1940 | Injection, furosemide, up to 20 mg | <1% | 56 | $68.08 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 14 | $61.67 |
| J3490 | Unclassified drugs | <1% | 390 | $27.39 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 22 | $15.62 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 17 | $9.34 |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 21 | $3.07 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKNIGHT, KIMBERLY (CFO)
Parent organizationHOSPITAL
| Provider | Location | Paid |
|---|---|---|
| Braxton County Memorial Hospital | Gassaway, WV | $4.93M |
| Braxton County Memorial Hospital | Gassaway, WV | $2.81M |
| Braxton County Memorial Hospital | Gassaway, WV | $1K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.